A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female Subjects
Clinical trial NCT03436849 · COMPLETED
Trial details
- NCT number
- NCT03436849
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2018-05-23
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.